ARLENE CLEMENTS
Pharmacy in Blenheim, NJ
License number
Pennsylvania PI088608L
Category
Pharmacy
Type
Pharmacy Intern
Address
Address
2
Blenheim, NJ 08012
Pennsylvania
Pennsylvania
Professional information
Pharmaceutical Agents
US Patent:
5993859, Nov 30, 1999
Filed:
Jul 13, 1998
Appl. No.:
9/114225
Inventors:
Robert Joseph Timko - West Chester PA
Randy John Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Randy John Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Assignee:
Zeneca Limited - London
International Classification:
A61K 916, A61K 920, C07D20910
US Classification:
424497
Abstract:
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methyl-benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.
Pharmaceutical Agents Useful As Leukotriene Antagonists
US Patent:
5482963, Jan 9, 1996
Filed:
Sep 3, 1993
Appl. No.:
8/116781
Inventors:
James J. Holohan - Macclesfield, GB2
Ieuan J. Edwards - Congleton, GB2
Robert J. Timko - West Chester PA
Randy J. Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Ieuan J. Edwards - Congleton, GB2
Robert J. Timko - West Chester PA
Randy J. Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Assignee:
Zeneca Limited - London
International Classification:
A61K 3140, C07D20912
US Classification:
514415
Abstract:
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.
Method Of Enhancing Bioavailability Of Pharmaceutical Agents
US Patent:
5612367, Mar 18, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/474191
Inventors:
Robert J. Timko - West Chester PA
Randy J. Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Randy J. Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Assignee:
Zeneca Limited - London
International Classification:
A61K 3140
US Classification:
514415
Abstract:
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.